Association Between Baseline LDH Levels and Immune-Related Adverse Events in Patients With Melanoma Receiving First-Line Immune Checkpoint Inhibitors
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of the American Academy of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Association between baseline lactate dehydrogenase and immune-related adverse events among patients with melanoma varies by tumor stage at immune checkpoint inhibitor initiation
J Am Acad Dermatol 2023 Aug 07;[EPub Ahead of Print], CX Pan, WC Lau, DY Kim, CB Lau, R Rowley, R Kanwar, NR LeBoeuf, VE NambudiriFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.